The FY15 Omnibus Appropriations Act contains $5.4 billion in emergency funding to address the Ebola crisis – a significant increase in total U.S. support for global health. Aside from the additional funding for Ebola, global health funding remained essentially flat at $9.2 billion, according to a new Kaiser Family Foundation…
- view as grid
- view as list
This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2015 Budget Request released on March 4, 2014. It examines funding by program area as well as trends over time.
This event examines the policy implications of the Institute of Medicine’s Evaluation of PEPAR
After Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.
During the 2008 Presidential campaign, now President Barack Obama and Republican presidential nominee Sen. John McCain announced a number of policy proposals and positions related to global health and the HIV/AIDS epidemic, both globally and domestically. This document summarizes those positions as staked out during the presidential campaign. It is…
Modeling the Impact of Global Health Budget Cuts on HIV, TB, Family Planning, and Maternal, Newborn, and Child Health
President Trump’s fiscal year 2018 budget request would cut global health programs by approximately $2.5 billion. As Congress begins considering the Administration’s request, a new Kaiser Family Foundation analysis models the potential impact of the Administration’s proposed budget, as well as two budget scenarios with more modest decreases. Among the…
This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.
With ongoing questions about future U.S. support for multilateral health efforts as well as important markers on the near horizon, including donor replenishment conferences for both the Global Fund and Gavi within the next two years, this brief highlights five key facts about U.S. engagement with multilateral global health organizations.
This issue brief provides an overview of the Biden administration’s COVID-19 and global health actions to date, as well as likely ones on the horizon, and identifies key policy issues and outstanding questions ahead.